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ABSTRACT
Objective: To elucidate the impact of the COVID-19 pandemic on
access to fertility services.
Methods: A retrospective quality improvement study was conducted at
a university-afﬁliated fertility practice in southwestern Ontario.
Annual procedural volumes for intrauterine and donor
inseminations (IUI/DI), in vitro fertilization and intracytoplasmic
sperm injections (IVF/ICSI), and frozen embryo transfers (FET)
during the COVID-19eaffected year were compared with mean
annual volumes from the 2 preceding years. In addition, volumes
for the same procedures were compared between the ﬁrst quarter
of 2021 and mean ﬁrst quarter volumes from 2018 to 2019.
Piecewise linear regressions were conducted to evaluate whether
any changes in monthly procedural volume were attributable to the
COVID-19 pandemic.
Results: In 2020, our fertility practice attained the mean annual
volumes of 89.7% for IUI/DI, 69.0% for IVF/ICSI, and 60.6% for
FET. In contrast, in 2021, we performed mean ﬁrst quarter volumes
of 130.1% for IUI/DI, 164.3% for IVF/ICSI, and 126.8% for FET. The
slopes of the pre- and posteCOVID-19 segments of the piecewise
linear regressions were signiﬁcantly different for IUI/DI (P < 0.001)
and IVF/ICSI (P ¼ 0.001), but not for FET (P ¼ 0.133).
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Conclusion: The COVID-19 pandemic resulted in decreased annual
volumes of medically assisted reproductive procedures at a
university-afﬁliated fertility practice in southwestern Ontario. Impact
on monthly procedural volume was conﬁrmed for IUI/DI and IVF/
ICSI by linear regression. Local adaptations helped compensate
and exceed expected volumes in 2021. As a result, the COVID-19
pandemic resulted in a short-lived limitation in access to fertility care.

RÉSUMÉ
Objectif : Examiner les répercussions de la pandémie de COVID-19
sur l’accès aux services de fertilité.
Méthodologie : Une étude rétrospective sur l’amélioration de la qualité
a été menée dans une pratique de traitement de l’infertilité afﬁliée à
une université dans le sud-ouest de l’Ontario. Les volumes annuels
des techniques pour l’insémination intra-utérine et l’insémination
avec sperme de donneur (IIU/IIUD), la fécondation in vitro et les
injections intracytoplasmiques d’un spermatozoïde (FIV/IICS) et les
transferts d’embryons congelés (TEC) au cours de l’année touchée
par la pandémie de COVID-19 ont été comparés aux volumes
annuels moyens des 2 années précédentes. De plus, les volumes
pour les mêmes techniques ont été comparés entre le premier
trimestre de 2021 et les volumes moyens du premier trimestre de
2018 et de 2019. Des régressions linéaires par segments ont été
réalisées pour évaluer si des changements dans les volumes
mensuels des techniques étaient attribuables à la pandémie de
COVID-19.
Résultats : En 2020, notre pratique de traitement de l’infertilité a atteint
des volumes annuels moyens de 89,7 % pour les IIU/IIUD, 69,0 %
pour les FIV/IICS et 60,6 % pour les TEC. Par comparaison, en
2021, nous avons réalisé des volumes moyens au premier
trimestre de 130,1 % pour les IIU/IIUD, 164,3 % pour les FIV/IICS et
126,8 % pour les TEC. Les courbes des segments pré- et postCOVID-19 des régressions linéaires par segments étaient
signiﬁcativement différentes pour les IIU/IIUD (p < 0,001) et les
FIV/IICS (p ¼ 0,001), mais pas pour les TEC (p ¼ 0,133).
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Conclusion : La pandémie de COVID-19 a entraîné une diminution
des volumes annuels des techniques de reproduction
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médicalement assistée dans une pratique universitaire de
traitement de l’infertilité du sud-ouest de l’Ontario. Des régressions
linéaires ont permis de conﬁrmer un effet sur le volume mensuel
des techniques d’IIU/IIUD et de FIV/IICS. Des adaptations locales
ont aidé à compenser cet effet et à dépasser les volumes prévus en
2021. Par conséquent, la pandémie de COVID-19 a entraîné une
limitation de courte durée de l’accès aux soins de l’infertilité.
ª 2021 The Society of Obstetricians and Gynaecologists of Canada/La
Société des obstétriciens et gynécologues du Canada. Published by
Elsevier Inc. All rights reserved.

J Obstet Gynaecol Can 2022;44(4):378-382
https://doi.org/10.1016/j.jogc.2021.10.017

INTRODUCTION

I

nability to access health care has been a described
effect of the coronavirus disease 2019 (COVID-19)
pandemic.1,2 The population of patients seeking fertility care
are under particular biological duress because they require
health care services to conceive, unlike their fertile counterparts. In addition, time is often a crucial factor underlying
many infertility diagnoses. As such, delays in care could
affect a patient’s ability to access government funding programs and have an impact on the success of treatments.
On March 18, 2020, following public health recommendations to cancel all non-essential procedures,3 the Canadian Fertility & Andrology Society (CFAS) advised
Canadian fertility centres to halt reproductive services.4 As
a result of the CFAS guidelines, centres for reproductive
care were shuttered across the country. The effect of
centre closures on the patient experience has been well
documented.5e7 However, the impact of these closures
and of adapted re-openings on procedural volume and
efﬁciency has yet to be examined.
The aim of our study was to elucidate the impact of the
COVID-19 pandemic on access to and availability of
fertility services, ﬁrst by quantifying the changes in procedural volumes during the pandemic at a universityafﬁliated fertility practice in Southwestern Ontario and
second by comparing the trends in procedural volumes
before and after the onset of the pandemic.
METHODS
Study Design

We conducted a retrospective quality improvement study
using data from a university-afﬁliated fertility practice
comprising 2 sites in London, Ontario. Monthly procedural volumes were tabulated for insemination

(intrauterine insemination [IUI]/donor insemination [DI]),
in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI), and frozen embryo transfer (FET) between
January 1, 2018, and May 31, 2021. All procedures were
captured in local databases at the hospital and ofﬁce-based
sites and included in the study.
Analysis

For the descriptive analysis, we quantiﬁed the change in
procedural volumes during the pandemic by comparing the
annual volumes achieved for IUI/DI, IVF/ICSI, and FET
in 2020 with the mean annual procedural volumes from
2018 and 2019. To compare the most recent procedural
volumes with pre-pandemic values, we compared the ﬁrstquarter volumes from 2021 to the mean ﬁrst-quarter volumes from 2018 and 2019. Because the ﬁrst quarter of 2020
coincided with the onset of the pandemic, we did not include
this period in the pre-pandemic analysis.
To compare the trends in procedural volumes before and
after the onset of the pandemic, we performed piecewise
linear regression models for IUI/DI, IVF/ICSI, and FET
separately. We used monthly procedural volumes during
pree and posteCOVID-19eaffected periods. A comparison of the 2 segments of the regression model was
tested against the null hypothesis that they could be
deﬁned by a single regression line.
We deﬁned the preeCOVID-19eaffected period as
January 1, 2018, to February 29, 2020, and the COVID19eaffected period as March 1, 2020, to May 31, 2021, the
end of our collection period. March 2020 was selected as
the start date for the COVID-19eaffected period because
it was the ﬁrst month affected by COVID-19 adaptations.
Owing to CFAS and Ontario Ministry of Health directives,3,4 fertility services were halted at our centres from
March 15, 2020, to June 7, 2020.
A third-party statistician used The R Project for Statistical
Computing, Version 4.0.2, to conduct statistical analyses.8
RESULTS

Analysis of medically assisted reproduction volumes for
2020 revealed that our clinics did not meet the mean
annual rates from the 2 preceding years. Our centres were
able to attain 89.7% of the mean annual IUI/DI volume
from 2018 to 2019, 69.0% of mean annual IVF/ICSI
volume, and 60.6% of mean annual FET volume.
Medically assisted reproduction volumes for the ﬁrst quarter
of 2021 (January to March) exceeded mean ﬁrst-quarter
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volumes from 2018 to 2019: 130.1% of mean ﬁrst-quarter
IUI/DI volume, 164.3% of mean ﬁrst-quarter IVF/ICSI
volume, and 126.8% of mean ﬁrst-quarter FET volume.
Piecewise linear regressions were used to compare the
trend in monthly procedural volumes between pree and
posteCOVID-19eaffected periods (Figure 1). Assumptions of the piecewise linear regression were tested against
the GausseMarkov theorem and were noted to satisfy the
following conditions: homoscedasticity and strict exogeneity. The residuals were not normally distributed, and as a
result they were modeled using ordinary least squares.
Regression models for each procedure had the following
measures of ﬁt: IUI/DI (F ¼ 6.1, R2 ¼ 0.34), IVF/ICSI
(F ¼ 4.1, R2 ¼ 0.25), and FET (F ¼ 1.0, R2 ¼ 0.08). The
pree and posteCOVID-19 procedural volume trends
were signiﬁcantly different for IUI/DI (P < 0.001) and
IVF/ICSI (P ¼ 0.001) but not for FET (P ¼ 0.133).
DISCUSSION

Whereas most studies on reproductive care during the
COVID-19 pandemic have focused on patient wellbeing,5e7
our study is the ﬁrst to quantify the effect of the pandemic on
availability of fertility services. The key ﬁndings of our study
demonstrate that there was a modest reduction in delivered
fertility services and procedures (IUI/DI e10.3%; IVF/ICSI
e31.0%; FET e39.4%) attributable to the COVID-19
pandemic. Although this was an anticipated ﬁnding with
known centre closures, the magnitude of the impact was not
previously described.

In contrast to mean ﬁrst-quarter ﬁgures before the pandemic,
the centre performed 30.1% more inseminations (IUI/DI),
64.3% more IVF/ICSI, and 26.8% more FET in the ﬁrst
quarter of 2021. The rise above pre-pandemic volumes may
be attributable to a resolution of patient backlog or more
efﬁcient procedure delivery after COVID-19 adaptations. In
the clinical context, our hospital site saw a trend towards an
increased live birth rate, from a preeCOVID-19 rate (January
2018 to November 2020, accounting for 9 months gestation)
of 476.7 births per month to 488.4 births per month rate
during the COVID-19 period (December 2020 to September
2021), although this was not statistically signiﬁcant (P ¼ 0.38).
We illustrated a signiﬁcant alteration in procedural volume
trends after the onset of the pandemic for IUI/DI (prepandemic m ¼ 0.4, post-pandemic m ¼ 6.0; P < 0.001) and
IVF/ICSI (pre-pandemic m ¼ e0.5, post-pandemic m ¼
3.0; P ¼ 0.001), although the same trend was not seen with
FET (pre-pandemic m ¼ e0.04, post-pandemic m ¼ 0.9;
P ¼ 0.133). The more modest difference in FET procedural
volumes would explain why the comparison did not meet
statistical signiﬁcance, but the same global trend was seen as
with IUI/DI and IVF/ICSI (Figure 1). A possible reason for
this smaller increase in FET volume may be related to patients
being more willing to delay transfer of a frozen embryo than
to delay the more age- and time-sensitive IVF/ICSI cycles.
Alternatively, COVID-19erelated delays in fresh IVF/ICSI
cycles may have resulted in a secondary paucity of frozen
embryos to transfer.
Our ﬁndings should be considered in the context of the
closures and setbacks experienced by our fertility practice.

Figure 1. Piecewise linear regression models for IUI/DI, IVF/ICSI, and FET to compare the trends in monthly procedural
volume before and after the onset of the COVID-19 pandemic.

PreeCOVID-19 was deﬁned as January 1, 2018, to February 29, 2020. PosteCOVID-19 was deﬁned as March 1, 2020, to May 31, 2021,
to incorporate the ﬁrst month affected by the pandemic. The breakpoint is delineated by a dotted line. P values refer to the comparison of
pree and posteCOVID-19 slopes.
COVID-19: coronavirus disease 2019; DI: donor insemination; FET: frozen embryo transfer; ICSI: intracytoplasmic sperm injection; IUI:
intrauterine insemination; IVF: in vitro fertilization.
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Figure 2. Local and systemic factors that contributed to decreased procedural volumes with COVID-19.

COVID-19: coronavirus disease 2019; DI: donor insemination; FET: frozen embryo transfer; ICSI: intracytoplasmic sperm injection;
IUI: intrauterine insemination; IVF: in vitro fertilization; PPE: personal protective equipment; TI: timed intercourse.

Our practice cancelled FET and donor insemination cycles
and converted IUI to timed intercourse. Following CFAS
guidance, this also meant conversion of ongoing IVF/ICSI
cycles to a freeze-all approach and adoption of virtual
care.4 Initially, reopening of our clinics was hampered by
capped numbers from Ontario Health regulations9 and
shortages of personal protective equipment and medications for conscious sedation. Locally, we experienced
decreased stafﬁng owing to hospital redeployment strategies and inefﬁcient screening procedures (Figure 2).
Our practice underwent numerous adaptations throughout
the pandemic, which may contextualize the increase in
quarterly procedural volume seen in 2021. These adaptations
are summarized in Figure 3 and may have led to an increase in
the efﬁciency of procedure delivery. Simpliﬁed insemination
procedures using urinary luteinizing hormone kits for
ovulation prediction decreased patient visits for ultrasound
and bloodwork. Virtual care also decreased requirements for

clinic space and stafﬁng, allowing multiple physicians to run
clinics concurrently. Universal patient masking, efﬁcient
screening, and updated computers and software for virtual
encounters helped to process patients faster. Omission of
holiday closures to compensate for expected losses started the
new year at an advantage. From a patient perspective, the
literature suggests there was a high degree of patient anxiety
regarding cycle cancellation,5e7 and this may explain
increased volumes on reopening.
As a single-practice study, our results may not be generalizable to the Canadian or global fertility populations.
There were also site-speciﬁc confounders to our data and
its analysis. Our hospital-based site was affected by a
centre closure for building maintenance between
December 20, 2019, and February 24, 2020. This affected
all of the medically assisted reproduction procedures, but
primarily IVF/ICSI and FET because they are only conducted at this site. As a result, the drop in annual volume

Figure 3. Ishikawa diagram enumerating factors that contributed to improved procedural efﬁciencies in the ﬁrst quarter of
2021.
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for IVF/ICSI and FET may be slightly overestimated, and
the true decrease attributable to the pandemic is likely
closer to the value for IUI/DI.
Although our study was limited to our single universityafﬁliated fertility practice, in a future study we hope to
explore the experiences of other Canadian reproductive
centres during the COVID-19 pandemic to characterize
how medically assisted reproduction was affected across
the nation.
CONCLUSION

The COVID-19 pandemic has had a signiﬁcant effect on
access to health care, including reproductive services. Our
study is the ﬁrst to provide a quantiﬁcation of this impact,
demonstrating an approximately 10% to 40% reduction in
medically assisted reproduction in 2020, depending on the
procedure. Month-to-month data showed a rapid recovery in
procedures performed after the clinic reopened, particularly
for IUI/DI and IVF/ICSI, with a nonsigniﬁcant trend for
FET. All medically assisted reproductive procedures saw a
recovery and exceeded projected volumes for the ﬁrst quarter
of 2021. As a result, the impact of COVID-19 on fertility
services was a deﬁned decrease in availability of procedures,
but one that was limited. Future research should evaluate how
fertility practices were affected on a national scale to illustrate
a more generalized picture.
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